LIVIVO - Search results -

Search results

Result 1 - 10 of total 54904

Search options

Article ; Online: Retrospective Multicenter Comparison of S.M.A.R.T. CONTROL and MISAGO Stents in Treatment of Femoropopliteal Lesions.

Suzuki, Kenji / Takahara, Mitsuyoshi / Shintani, Yoshiaki / Tanaka, Akiko / Soga, Yoshimitsu / Yamaoka, Terutoshi / Tosaka, Atsushi / Sasaki, Shinya / Kawasaki, Daizo / Tsuchiya, Taketsugu / Kozuki, Amane / Iida, Osamu

Journal of vascular and interventional radiology : JVIR

2016 Volume 27, Issue 11, Page(s) 1642–1649

Abstract: ... retrospective study included 240 cases with MISAGO stent implantation and 1,265 cases with S.M.A.R.T. stent ... implantation. The S.M.A.R.T. group had more Trans-Atlantic Inter-Society of Consensus (TASC) II class C/D ... P < .001).: Results: Kaplan-Meier estimates of 2-year primary patency after S.M.A.R.T. and MISAGO ...

Abstract	Purpose: To compare primary patency between MISAGO (Terumo Corporation, Tokyo, Japan) and S.M.A.R.T. CONTROL (Cordis Corporation, Miami Lakes, Florida), second-generation and first-generation nitinol stents, in femoropopliteal lesions. Materials and methods: This multicenter, retrospective study included 240 cases with MISAGO stent implantation and 1,265 cases with S.M.A.R.T. stent implantation. The S.M.A.R.T. group had more Trans-Atlantic Inter-Society of Consensus (TASC) II class C/D lesions (53% vs 41%, P = .001) and smaller reference vessel diameter (RVD) (5.3 mm ± 0.9 vs 5.5 mm ± 0.9, P < .001). Results: Kaplan-Meier estimates of 2-year primary patency after S.M.A.R.T. and MISAGO stent implantation were 67% and 55% (P = .007). Interaction analysis revealed that TASC II classification and RVD had a significant influence on the association of MISAGO versus S.M.A.R.T. stents with the outcome. The study population was stratified according to TASC II classification and RVD, and MISAGO and S.M.A.R.T. stents were compared after propensity score matching. There was no significant difference in 2-year patency between the 2 stents in the subgroup with TASC II class A/B and RVD ≥ 5 mm (S.M.A.R.T. 82% ± 4 vs MISAGO 74% ± 5, P = .480). MISAGO stents had lower primary patency than S.M.A.R.T. stents in cases with TASC II class C/D or RVD < 5 mm (S.M.A.R.T. 62% ± 6 vs MISAGO 25% ± 6, P = .015). Conclusions: S.M.A.R.T. and MISAGO stents had similar patency in simple lesions, but MISAGO stents had lower patency than S.M.A.R.T. stents in more complex lesions.
MeSH term(s)	Aged ; Aged, 80 and over ; Alloys ; Constriction, Pathologic ; Endovascular Procedures/adverse effects ; Endovascular Procedures/instrumentation ; Female ; Femoral Artery/diagnostic imaging ; Femoral Artery/physiopathology ; Humans ; Japan ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Peripheral Arterial Disease/diagnostic imaging ; Peripheral Arterial Disease/physiopathology ; Peripheral Arterial Disease/therapy ; Popliteal Artery/diagnostic imaging ; Popliteal Artery/physiopathology ; Propensity Score ; Proportional Hazards Models ; Prosthesis Design ; Prosthesis Failure ; Recurrence ; Retrospective Studies ; Self Expandable Metallic Stents ; Time Factors ; Treatment Outcome ; Vascular Patency
Chemical Substances	Alloys ; nitinol (2EWL73IJ7F)
Language	English
Publishing date	2016-11
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Multicenter Study
ZDB-ID	1137756-2
ISSN	1535-7732 ; 1051-0443
ISSN (online)	1535-7732
ISSN	1051-0443
DOI	10.1016/j.jvir.2016.05.042
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3720: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Efficacy of the S.M.A.R.T. Control vs. other stents for aortoiliac occlusive disease in contemporary clinical practice.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

2013 Volume 20, Issue 3, Page(s) 431–439

Abstract: Purpose: To compare the safety and efficacy of the S.M.A.R.T. Control stent vs. other stents ... between April 2005 and December 2009. The cohort was divided into the S.M.A.R.T. stent group (955 patients ... TLR), and major adverse limb events were also assessed.: Results: The S.M.A.R.T. Control stent ...

Abstract	Purpose: To compare the safety and efficacy of the S.M.A.R.T. Control stent vs. other stents in patients with symptomatic aortoiliac occlusive disease (AIOD) followed for up to 4 years. Methods: A subgroup analysis of data from a retrospective multicenter registry examined 2036 symptomatic patients (1659 men; mean age 71±8 years) who received stent-supported endovascular therapy for 2541 AIOD lesions between April 2005 and December 2009. The cohort was divided into the S.M.A.R.T. stent group (955 patients/1196 lesions) and the "other" stent group (1081 patients/1345 lesions). The main study outcomes of primary patency and event-free survival at 4 years were compared before and after propensity matching analysis. The rates for freedom from major amputation, surgical conversion, target lesion revascularization (TLR), and major adverse limb events were also assessed. Results: The S.M.A.R.T. Control stent group had greater frequency of critical limb ischemia (CLI), TASC C/D lesions, and chronic total occlusions. The mean follow-up was 25±17 months in the S.M.A.R.T. group vs. 29±19 months in the other stent group. After propensity matching, 4-year primary patency (86% vs. 76%, p<0.001) and freedom from adverse limb events (93% vs. 90%, p=0.04) were greater in the S.M.A.R.T. Control stent group, while event-free survival rates (75% vs. 77%, p=0.50) were similar between groups. Univariate subgroup analysis showed that use of the S.M.A.R.T. stent was associated with greater primary patency in patients with renal insufficiency (serum creatinine >1.5 mg/dL) and CLI. Conclusion: After propensity matching analysis, the durability of the S.M.A.R.T. stent was superior to that of other stents, which might reflect differing design characteristics.
MeSH term(s)	Aged ; Aortic Diseases/surgery ; Arterial Occlusive Diseases/surgery ; Endovascular Procedures/methods ; Female ; Humans ; Iliac Artery/surgery ; Male ; Prosthesis Design ; Retrospective Studies ; Stents
Language	English
Publishing date	2013-06
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Multicenter Study
ZDB-ID	2006618-1
ISSN	1545-1550 ; 1526-6028
ISSN (online)	1545-1550
ISSN	1526-6028
DOI	10.1583/12-4156MR.1
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4547: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry.

Suzuki, Kenji / Iida, Osamu / Soga, Yoshimitsu / Hirano, Keisuke / Inoue, Naoto / Uematsu, Masaaki / Yokoi, Hiroyoshi / Muramatsu, Toshiya / Nanto, Shinsuke / Nobuyoshi, Masakiyo / Meguro, Taiichiro

Circulation journal : official journal of the Japanese Circulation Society

2011 Volume 75, Issue 4, Page(s) 939–944

Abstract: ... in which the S.M.A.R.T. Control(TM) stent was used for treatment of de novo SFA lesions. A total of 528 lesions ... <0.01) were independent predictors of re-stenosis.: Conclusions: The S.M.A.R.T. Control(TM) stent ...

Abstract	Background: The use of a stent in the treatment of lesions of the superficial femoral artery (SFA) remains controversial. Although some reports have suggested that use of a nitinol stent in conjunction with aggressive medical management is effective for long SFA lesions, few long-term, large-scale studies have been done. Methods and results: A retrospective analysis was conducted of data from a multicenter study in which the S.M.A.R.T. Control(TM) stent was used for treatment of de novo SFA lesions. A total of 528 lesions in 432 patients were included. Mean patient age was 72.5±9.1 years; mean stent length was 15.7±8.1cm; 259 lesions (49%) were classified as C/D according to the TransAtlantic Inter-Society Consensus (TASC) II classification. Primary and secondary patency at 4 years was 66% and 87%, respectively. No cilostazol administration (41% re-stenosis group vs. 29% no-restenosis group, P<0.01), female gender (42% vs. 26%, P<0.01), younger age (70.7±9.3 years vs. 72.9±9.0 years, P<0.05), and chronic total occlusion (CTO; 72% vs. 52%, P<0.01) were independent predictors of re-stenosis. Conclusions: The S.M.A.R.T. Control(TM) stent provided good long-term durability in the treatment of SFA lesions, and no cilostazol administration, female gender, younger age and CTO were associated with re-stenosis.
MeSH term(s)	Age Factors ; Aged ; Aged, 80 and over ; Cilostazol ; Female ; Femoral Artery ; Follow-Up Studies ; Graft Occlusion, Vascular/etiology ; Graft Occlusion, Vascular/prevention & control ; Humans ; Male ; Middle Aged ; Peripheral Arterial Disease/therapy ; Registries ; Stents ; Tetrazoles/administration & dosage ; Tetrazoles/adverse effects ; Time Factors ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects
Chemical Substances	Tetrazoles ; Vasodilator Agents ; Cilostazol (N7Z035406B)
Language	English
Publishing date	2011-02-11
Publishing country	Japan
Document type	Clinical Trial ; Journal Article ; Multicenter Study
ZDB-ID	2068090-9
ISSN	1347-4820 ; 1346-9843
ISSN (online)	1347-4820
ISSN	1346-9843
DOI	10.1253/circj.cj-10-1029
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui IV Zs.74: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Suzuki, Hideaki / Sekine, Shinichi / Kataoka, Kosuke / Pascual, David W / Maddaloni, Massimo / Kobayashi, Ryoki / Fujihashi, Keiko / Kozono, Haruo / McGhee, Jerry R / Fujihashi, Kohtaro

Gastroenterology

2008 Volume 135, Issue 3, Page(s) 917–925

Abstract: ... subsequent induction of mucosal immunity. In this study, we examined whether M-cell targeting using a protein ... T-cell responses were determined.: Results: A low dose of OVA-psigma1 reduced anti-OVA Ab and CD4 ... T-cell responses in both mucosal and systemic lymphoid tissues. OVA/MHC I-A(d) tetramer staining ...

Abstract	Background & aims: The follicle-associated epithelium (FAE) plays key roles in antigen uptake and subsequent induction of mucosal immunity. In this study, we examined whether M-cell targeting using a protein antigen (Ag) delivery system would induce oral tolerance instead of enhancement of Ag-specific mucosal antibody (Ab) responses. Methods: Mice were fed different doses of a recombinant protein sigma 1 of reovirus genetically conjugated to ovalbumin (OVA-psigma1), psigma1 only, or phosphate-buffered saline (PBS) before oral challenge with OVA plus cholera toxin as mucosal adjuvant. OVA-specific Ab and CD4-positive (CD4(+)) T-cell responses were determined. Results: A low dose of OVA-psigma1 reduced anti-OVA Ab and CD4(+) T-cell responses in both mucosal and systemic lymphoid tissues. OVA/MHC I-A(d) tetramer staining showed that the numbers of OVA-specific CD4(+) T cells were significantly reduced in lamina propria of mice fed OVA-psigma1 than those fed psigma1 only or PBS only. In fact, Foxp3 expressing CD25(+) CD4(+) T cells were markedly increased in this tissue. Nonetheless, CD25(+) CD4(+) T cells from the spleen, mesenteric lymph nodes, and Peyer's patches of orally tolerized mice showed increased transforming growth factor beta1 (TGF-beta1) and interleukin-10 (IL-10) production compared with nontolerized mice. Conclusions: These results show that an FAE M-cell targeting protein Ag delivery system facilitates oral tolerance induction because of a reduction in Ag-specific CD4(+) T cells and increased levels of TGF-beta1 and IL-10 producing, CD25(+) CD4(+) regulatory T cells in both systemic and mucosal lymphoid tissues.
MeSH term(s)	Administration, Oral ; Animals ; Antibody Formation ; CD4-Positive T-Lymphocytes/immunology ; Capsid Proteins/immunology ; Epitopes ; Immune Tolerance ; Immunity, Mucosal ; Immunization ; Interferon-gamma/analysis ; Lymphoid Tissue/cytology ; Lymphoid Tissue/immunology ; Mice ; Mice, Inbred BALB C ; Mouth Mucosa/cytology ; Mouth Mucosa/immunology ; Ovalbumin/administration & dosage ; Ovalbumin/immunology ; Transforming Growth Factor beta1/analysis
Chemical Substances	Capsid Proteins ; Epitopes ; Transforming Growth Factor beta1 ; sigma 1 protein, reovirus ; Interferon-gamma (82115-62-6) ; Ovalbumin (9006-59-1)
Language	English
Publishing date	2008-05-15
Publishing country	United States
Document type	Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID	80112-4
ISSN	1528-0012 ; 0016-5085
ISSN (online)	1528-0012
ISSN	0016-5085
DOI	10.1053/j.gastro.2008.05.037
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui V Zs.44: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 572: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: [Application of macrophage migration inhibition test (M.I.T.) in syphilis in man].

Tanaka, S / Tomigashi, H / Suzuki, T / Numata, G / Onoda, Y

Nihon saikingaku zasshi. Japanese journal of bacteriology

1975 Volume 30, Issue 1, Page(s) 81

MeSH term(s)	Cell Migration Inhibition ; Humans ; Macrophages/immunology ; Syphilis Serodiagnosis
Language	Japanese
Publishing date	1975-01
Publishing country	Japan
Document type	Journal Article
ZDB-ID	604101-2
ISSN	1882-4110 ; 0021-4930
ISSN (online)	1882-4110
ISSN	0021-4930
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 577: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Blue toe syndrome caused by spontaneous cholesterol embolization syndrome.

Suzuki, M / Watari, T

QJM : monthly journal of the Association of Physicians

2023 Volume 116, Issue 11, Page(s) 936–937

MeSH term(s)	Humans ; Blue Toe Syndrome/etiology ; Embolism, Cholesterol/complications ; Embolism, Cholesterol/diagnosis
Language	English
Publishing date	2023-07-19
Publishing country	England
Document type	Journal Article
ZDB-ID	1199985-8
ISSN	1460-2393 ; 0033-5622 ; 1460-2725
ISSN (online)	1460-2393
ISSN	0033-5622 ; 1460-2725
DOI	10.1093/qjmed/hcad169
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.131: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Resuming automated peritoneal dialysis after laparoscopic peritoneal wall anchoring for peritoneal dialysis catheter fixation.

Matsunami, Masatoshi / Suzuki, Tomo / Suzuki, Koichiro / Kuji, Hiroshi

Journal of nephrology

2024

Language	English
Publishing date	2024-03-21
Publishing country	Italy
Document type	Journal Article
ZDB-ID	1093991-x
ISSN	1724-6059 ; 1120-3625 ; 1121-8428
ISSN (online)	1724-6059
ISSN	1120-3625 ; 1121-8428
DOI	10.1007/s40620-024-01917-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3369: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: IgG4-Related Membranous Nephropathy After COVID-19 Vaccination: A Case Report.

Mizuno, Tomohito / Endo, Yoko / Suzuki, Atsushi / Suzuki, Masashi

Cureus

2024 Volume 16, Issue 3, Page(s) e56028

Abstract: Although immunoglobulin G4 (IgG4)-related kidney diseases are typically characterized by tubulointerstitial nephritis with abundant infiltration of IgG4-positive plasma cells and fibrosis, there have been relatively rare cases of IgG4-related ... ...

Abstract	Although immunoglobulin G4 (IgG4)-related kidney diseases are typically characterized by tubulointerstitial nephritis with abundant infiltration of IgG4-positive plasma cells and fibrosis, there have been relatively rare cases of IgG4-related glomerulonephritis. Several cases of IgG4-related disease (IgG4-RD) following coronavirus disease 2019 (COVID-19) mRNA vaccination have been reported. However, there are no reports of IgG4-related glomerulonephritis following COVID-19 vaccination. Herein, we present a case of IgG4-related membranous nephropathy (MN) occurring after COVID-19 vaccination. A 69-year-old Japanese male presented to our hospital with edema that started the day after his second COVID-19 vaccination. The patient exhibited nephrotic syndrome and was diagnosed with MN based on the results of a kidney biopsy. Although serum IgG4 levels were elevated to 946 mg/dL, no evidence of organ involvement suggestive of IgG4-RD was observed. Treatment with prednisolone and cyclosporine resulted in complete remission, and immunosuppressive agents were tapered. However, one month after discontinuing the immunosuppressive agents, the patient was readmitted with swelling around the submandibular glands and exertional dyspnea. Serum IgG4 level was markedly elevated at 2,320 mg/dL, and computed tomography revealed submandibular gland swelling and thickening of the interlobular septum and bronchovascular bundles in both lungs. The patient was diagnosed with IgG4-RD based on elevated serum IgG4 levels and infiltration of IgG4-positive plasma cells in the submandibular gland biopsy. Upon resuming treatment with prednisolone, the symptoms attributed to IgG4-RD improved within a few days. In cases of nephrotic syndrome following COVID-19 vaccination, it may be advisable to conduct detailed examinations to assess the possibility of the development of IgG4-RDs.
Language	English
Publishing date	2024-03-12
Publishing country	United States
Document type	Case Reports
ZDB-ID	2747273-5
ISSN	2168-8184
ISSN	2168-8184
DOI	10.7759/cureus.56028
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Efficacy of zinc acetate hydrate for hypozincemia in the elderly is influenced by the initial accumulated exposure dose after taking zinc acetate hydrate.

So, M / Tsuji, Y / Suzuki, T

Die Pharmazie

2023 Volume 78, Issue 9, Page(s) 201–206

Abstract: This study aimed to determine the efficacy of zinc acetate hydrate (ZAH) for hypozincemia in elderly hospitalized patients with an accumulated exposure of < 1000 mg of ZAH and to explore the factors affecting the therapeutic efficacy of ZAH. Seventy-four ...

Abstract	This study aimed to determine the efficacy of zinc acetate hydrate (ZAH) for hypozincemia in elderly hospitalized patients with an accumulated exposure of < 1000 mg of ZAH and to explore the factors affecting the therapeutic efficacy of ZAH. Seventy-four patients (mean age, 82 years) were enrolled in this study. All patients (n = 74) had low serum zinc levels (< 80 μg/dL), and the mean serum zinc concentration before ZAH administration was 53.6±10.7 μg/dL. The median serum zinc level (μg/dL) elevated per tablet (25 mg) of ZAH was 1.26 μg/dL, and the patients were divided into two groups, the slightly increased (< 1.26) and significantly increased (≥ 1.26) groups, based on the median cutoff value for the median increase in serum zinc level. A significant difference was found between the slightly increased (0.63±0.35 μg/dL, n = 36) and significantly increased (2.37±0.95 μg/dL, n = 38) groups (p < 0.0001, Wilcoxon rank-sum test). Logistic regression analysis with the accumulated exposure dose of ZAH, sex, and body weight as multivariate variables showed a significant difference in the accumulated exposure dose (total number of tablets per 25 mg: odds ratio, 1.119; 95% confidence interval, 1.052???1.203; p = 0.0009). There was no effect of underlying disease or of diet or zinc-containing intravenous or enteral nutrition on serum zinc levels. These results suggest that at an accumulated exposure of < 1000 mg of ZAH, serum zinc levels tend to increase with smaller accumulated doses. Therefore, serum zinc concentrations should be measured at the accumulated exposure to 500-1000 mg after ZAH initiation for the treatment of zinc deficiency in elderly hospitalized patients.
MeSH term(s)	Humans ; Aged ; Aged, 80 and over ; Zinc Acetate ; Zinc ; Body Weight ; Diet
Chemical Substances	Zinc Acetate (FM5526K07A) ; Zinc (J41CSQ7QDS)
Language	English
Publishing date	2023-11-30
Publishing country	Germany
Document type	Journal Article
ZDB-ID	208793-5
ISSN	0031-7144
ISSN	0031-7144
DOI	10.1691/ph.2023.3576
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uf I Zs.145: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Effect of acid suppressant medications on the laxative action of magnesium preparations in patients with opioid-induced constipation: A pharmacovigilance analysis of the FDA Adverse Event Reporting System.

Maezawa, M / Inoue, M / Satake, R / Wakabayashi, W / Oura, K / Goto, F / Miyasaka, K / Hirofuji, S / Iwata, M / Suzuki, T / Tanaka, H / Nishida, S / Shimizu, S / Suzuki, A / Iguchi, K / Nakamura, M

Die Pharmazie

2024 Volume 78, Issue 11, Page(s) 245–250

Abstract: ... ...

Abstract	Objective
MeSH term(s)	United States/epidemiology ; Humans ; Laxatives/adverse effects ; Analgesics, Opioid/adverse effects ; Constipation/chemically induced ; Constipation/epidemiology ; Magnesium/therapeutic use ; Opioid-Induced Constipation/drug therapy ; Pharmacovigilance
Chemical Substances	Laxatives ; Analgesics, Opioid ; Magnesium (I38ZP9992A)
Language	English
Publishing date	2024-01-04
Publishing country	Germany
Document type	Journal Article
ZDB-ID	208793-5
ISSN	0031-7144
ISSN	0031-7144
DOI	10.1691/ph.2023.3624
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uf I Zs.145: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito